ID

36281

Description

A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02447328

Link

https://clinicaltrials.gov/show/NCT02447328

Keywords

Versions (1)
  1. 4/29/19 4/29/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

April 29, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Locally Advanced or NCT02447328

English

Eligibility Locally Advanced or NCT02447328

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
postmenopausal women
Description

Postmenopausal state

Data type

boolean

Alias
UMLS CUI [1]
C0232970
postmenopausal: amenorrhea over 12 months prior to the visit 1 or history of hysterectomy ２) outpatient or inpatient with locally advanced or metastatic breast cancer who have failed with prior anti-estrogen therapy.
Description

Postmenopausal state | Amenorrhea Duration | Hysterectomy | Outpatients | Inpatient | Locally advanced breast cancer | Secondary malignant neoplasm of female breast | Prior antiestrogen therapy failed

Data type

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2,1]
C0002453
UMLS CUI [2,2]
C0449238
UMLS CUI [3]
C0020699
UMLS CUI [4]
C0029921
UMLS CUI [5]
C0021562
UMLS CUI [6]
C3495949
UMLS CUI [7]
C0346993
UMLS CUI [8,1]
C0279797
UMLS CUI [8,2]
C0231175
estrogen receptor positive ４)radiographic progression of disease after the prior therapy ５) patients who agree to participate in this study and sign the informed consent
Description

Patients Estrogen receptor positive | Disease Progression Radiography | Status post Prior Therapy | Informed Consent

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0279754
UMLS CUI [2,1]
C0242656
UMLS CUI [2,2]
C0034571
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C1514463
UMLS CUI [4]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who are treated with fulvestrant
Description

fulvestrant

Data type

boolean

Alias
UMLS CUI [1]
C0935916
patients who are being treated with the other antitumor agents
Description

Antineoplastic Agents

Data type

boolean

Alias
UMLS CUI [1]
C0003392
pregnancy or lactating women
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of hypersensitivity to any of included ingredients (eg. castor oil) ５) patients who are considered not fit for the study by investigators
Description

Hypersensitivity Ingredient | Castor oil allergy | Patients Medically unfit

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1550600
UMLS CUI [2]
C0571232
UMLS CUI [3,1]
C0030705
UMLS CUI [3,2]
C3841806
patients who have severe dysfunction of liver or kidney
Description

Liver Dysfunction Severe | Renal dysfunction Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0086565
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C3279454
UMLS CUI [2,2]
C0205082
total bilirubin > 5 x uln
Description

Elevated total bilirubin

Data type

boolean

Alias
UMLS CUI [1]
C0741494
ast/alt > 5 x uln
Description

Aspartate aminotransferase increased | Alanine aminotransferase increased

Data type

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
creatinine > 2 x uln
Description

Creatinine increased

Data type

boolean

Alias
UMLS CUI [1]
C0151578
Back to the top of the page

Similar models

Eligibility Locally Advanced or NCT02447328

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Postmenopausal state
Item
postmenopausal women
boolean
C0232970 (UMLS CUI [1])
Postmenopausal state | Amenorrhea Duration | Hysterectomy | Outpatients | Inpatient | Locally advanced breast cancer | Secondary malignant neoplasm of female breast | Prior antiestrogen therapy failed
Item
postmenopausal: amenorrhea over 12 months prior to the visit 1 or history of hysterectomy ２) outpatient or inpatient with locally advanced or metastatic breast cancer who have failed with prior anti-estrogen therapy.
boolean
C0232970 (UMLS CUI [1])
C0002453 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0020699 (UMLS CUI [3])
C0029921 (UMLS CUI [4])
C0021562 (UMLS CUI [5])
C3495949 (UMLS CUI [6])
C0346993 (UMLS CUI [7])
C0279797 (UMLS CUI [8,1])
C0231175 (UMLS CUI [8,2])
Patients Estrogen receptor positive | Disease Progression Radiography | Status post Prior Therapy | Informed Consent
Item
estrogen receptor positive ４)radiographic progression of disease after the prior therapy ５) patients who agree to participate in this study and sign the informed consent
boolean
C0030705 (UMLS CUI [1,1])
C0279754 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2,1])
C0034571 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C1514463 (UMLS CUI [3,2])
C0021430 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
fulvestrant
Item
patients who are treated with fulvestrant
boolean
C0935916 (UMLS CUI [1])
Antineoplastic Agents
Item
patients who are being treated with the other antitumor agents
boolean
C0003392 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hypersensitivity Ingredient | Castor oil allergy | Patients Medically unfit
Item
history of hypersensitivity to any of included ingredients (eg. castor oil) ５) patients who are considered not fit for the study by investigators
boolean
C0020517 (UMLS CUI [1,1])
C1550600 (UMLS CUI [1,2])
C0571232 (UMLS CUI [2])
C0030705 (UMLS CUI [3,1])
C3841806 (UMLS CUI [3,2])
Liver Dysfunction Severe | Renal dysfunction Severe
Item
patients who have severe dysfunction of liver or kidney
boolean
C0086565 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C3279454 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Elevated total bilirubin
Item
total bilirubin > 5 x uln
boolean
C0741494 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
ast/alt > 5 x uln
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Creatinine increased
Item
creatinine > 2 x uln
boolean
C0151578 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial